Does intensive blood-glucose lowering reduce the risk of cardiovascular disease in patients with type 2 diabetes

Does intensive blood-glucose lowering reduce the risk of cardiovascular disease in patients with type 2 diabetes?

We know that lowering A1C decreases the risk of microvascular disease such as retinopathy and nephropathy.

So many experts hoped it would also improve MACROvascular outcomes such as heart attacks and strokes.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote